Admission Date:  [**2189-11-16**]              [**Month/Day/Year **] Date:   [**2189-12-8**]  Date of Birth:  [**2123-7-19**]             Sex:   F  Service: MEDICINE  Allergies: Codeine / Plavix / Aspirin  Attending:[**First Name3 (LF) 3913**] Chief Complaint: B/L knee replacement  Major Surgical or Invasive Procedure: B/L knee replacement intubation a-line placement central line placement   History of Present Illness: Pt is a 66 y/o woman w/ a PMH of CMML, HTN, DM, AS (s/p bio-prosthetic AVR), and CVA who was admitted for bilateral total knee replacements.
She was found to be in PEA on transfer to the [**Hospital Unit Name 153**] and received atropine and epi w/ return of a perfusing rhythm.
She was started on pressors at this time.
She responded to PRBC infusions and has been stable afterwards.
She developed severe CHF and required lasix gtt but had been auto-diuresing prior to call-out and her respiratory status has improved significantly w/ diuresis.
Her pressors were slowly weaned and she was eventually started on an ace-i and bb secondary to her new dx of CHF and low EF.
She was originally started on vanco/zosyn when she developed hypotension [**2-18**] concerns of sepsis but these were d/c'ed after her BP improved and all her cultures remained negative.
CMML (Chronic Myelomonocytic Leukemia): Diagnosed in [**2184**], status post splenic radiation total 750 rads in 15 treatments 2.
S/p AVR [**8-20**] 3.
Thyroid cancer, status post total thyroidectomy.
Total abdominal hysterectomy for menorrhagia 9.
S/p Cholecystectomy [**94**].
S/p benign breast mass excisionx 2   Social History: Denied any tobacco, alcohol, or intravenous drug abuse.
Physical Exam: Overweight woman lying in bed in NAD, raspy voice, - rashes HEENT: EOMI, PERRLA, MMM, O/P clear Neck: - LAD Lungs: CTA b/l CV: RRR, S1/S2 intact, 2/6 SEM at the USB Abd: S/NT/ND, +BS Ext: B/L knee surgical sites C/D/I w/out sign of infection, + LE edema Neuro: CN 2-12 grossly intact, AAO x3  Pertinent Results: [**2189-11-16**] 07:00PM   CK(CPK)-49 [**2189-11-16**] 07:00PM   CK-MB-2 [**2189-11-16**] 01:28PM   CK(CPK)-36 [**2189-11-16**] 01:28PM   CK-MB-2 cTropnT-0.03*  TTE [**2189-11-20**] The left atrium is dilated.
Overall left ventricular systolic  function is moderately-to-severely depressed (ejectoion fraction 30 percent)  secondeary to severe hypokinesis of the anterior septum, anterior free wall,  and apex.
A bioprosthetic aortic valve prosthesis is present.
The aortic prosthesis appears well seated, with normal  leaflet/disc motion and transvalvular gradients.
Enlarged right axillary and mediastinal lymph nodes of uncertain clinical significance.
The common bile duct measures 6 mm, which is normal for a post-cholecystectomy state.
KNEE 2 VIEW PORTABLE BILAT  [**2189-11-16**] 1:33 PM  BOTH KNEES: Two nonstandard views show bilateral new total knee prostheses.
Skin staples and drains are in place.
IMPRESSION: Status post bilateral total knee arthroplasty.
Brief Hospital Course: A/P: 66 y/o f with CMML, AVR, DM2, HTN admitted for bilateral total knee replacements who developed shock and hypoxemic respiratory failure on post-op day 1 .
Cardiology was consulted and they felt that her decreased LV systolic dysfunction was post-arrest given her clean coronaries in [**2188**] in cath for pre-op for her AVR.
The patient autodiuresed well on the floor and was eventually weaned off her O2 requirement.
Cardiology was consulted who recommended lasix 40 mg PO QD for fluid overload.
WBC count rising so restarted on hydroxyurea on [**11-22**], and prednisone on [**12-2**].
Knees - Pt received her bilateral knee replacement for her DJD and was followed by ortho throughout her course.
Stage 2-3 ulcer R heel - Patient developed ulcer from CPM machine as part of her rehab for her s/p TKR, which remained uninfected.
Wound management followed, and it was cleaned with sterile water, pat dried and dressed with a duoderm bandage and Kerlex bandage QD.
Pantoprazole 40 mg Tablet [**Hospital1 **] 2.
Danazol 200 mg Capsule Sig: PO Q12H 3.
Hydroxyurea 500 mg Capsule PO DAILY 4.
Prednisone 2.5 mg Tablet Three Tablet PO DAILY 5.
Captopril 12.5 mg Tablet 1 Tablet PO BID 6.
Allopurinol 100 mg Tablet 1 Tablet PO DAILY 7.
Levothyroxine Sodium 112 mcg 1 Tablet PO DAILY 8.
Furosemide 20 mg Tablet 1 Tablet PO DAILY 9.
Multivitamin 11.
Vitamin E 400 unit [**Unit Number **].
Zyrtec 10 mg Tablet 13.
Reglan 10 mg Tablet 1 PO TID   [**Unit Number **] Medications: 1.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed.
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed.
Enoxaparin 30 mg/0.3 mL Syringe Sig: One (1)  Subcutaneous Q12H (every 12 hours).
Prednisone 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): for a total of 12.5 mg PO QD.
Prednisone 2.5 mg Tablet Sig: One (1) Tablet PO once a day: for total dose of 12.5 mg PO QD.
Lactulose 10 g/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day).
Hydroxyurea 500 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q4H (every 4 hours).
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours).
Oxycodone 5 mg/5 mL Solution Sig: One (1)  PO Q4-6H (every 4 to 6 hours) as needed.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Levothyroxine Sodium 112 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Allopurinol 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical  TID (3 times a day) as needed for [**Female First Name (un) **] skin infection.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Captopril 12.5 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Magnesium Oxide 400 mg Tablet Sig: Two (2) Tablet PO once a day.
Calcium Acetate 667 mg Capsule Sig: One (1) Capsule PO QD with meal.
[**Female First Name (un) **] Disposition: Extended Care  Facility: [**Hospital1 700**] - [**Location (un) 701**]  [**Location (un) **] Diagnosis: Primary: Shock Hypoxic respiratory failure S/p bilateral total knee replacements Probable myocardial infarction with new left bundle branch block and wall motion abnormalities Chronic Myelomonocytic Leukemia status post radiation therapy and splenectomy Stage II-III pressure ulcer on Right heel  Secondary: Aortic stenosis status post bio-prosthetic Aortic Valve Replacement Hypertension Diabetes Mellitus 2 Hypertension Thyroid cancer status post thyroidectomy Cerebral Vascular Accident x 2 Gastroesophageal Reflux Disease status post cholecystectomy   [**Location (un) **] Condition: Fair   [**Location (un) **] Instructions: 1.
Please take all medications as prescribed.
